Elisabeta Gherga

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

Xu-Shan Sun, Yungan Tao, Christophe Le Tourneau et al. · The Lancet Oncology · 2020 · 124 citations

Radiation Therapy, Medicine, High-dose Cisplatin Chemoradiotherapy +9

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Yungan Tao, Xu-Shan Sun, Y. Pointreau et al. · European Journal of Cancer · 2023 · 48 citations · Full text

Approach to Oligometastatic Disease in Head and Neck Cancer, on Behalf of the GORTEC

Xu Sun, Cécile Michel, E. Babin et al. · Future Oncology · 2018 · 38 citations

Surgical Oncology, Neck Cancer, Neoadjuvant Therapy +24

PET-based prognostic survival model after radiotherapy for head and neck cancer

J. Castelli, Adrien Depeursinge, Anne Devillers et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 24 citations · Full text

Adaptive Radiotherapy, Neck Cancer, Radiation Therapy +11

FOLFOXIRI <i>vs</i> FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study

Angélique Vienot, Hortense Chevalier, Clément Bolognini et al. · World Journal of Gastrointestinal Oncology · 2020 · 17 citations · Full text